Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Karma CREME-1
2018-000573-72Phase 2Completed
- Sponsor
- Atossa Therapeutics
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of z-endoxifen in Dense Breast Tissue (DBT) (3 arms), sponsored by Atossa Therapeutics. Primary endpoints: Change in mammographic breast density at 3 months and Change in mammographic breast density at 6 months. Started Feb 2018; status: completed.
02
Drugs
z-endoxifen
03
Conditions
Dense Breast Tissue (DBT)
Beyond the preview
Go deeper on 2018-000573-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000573-72.